 | Form 4 Filings | Insider Buys | Significant Buys | Penny Stocks Insider Buying | Insider Sales |
| Insider Buy Sell Ratios | Stock Options | Insider Trading Stock Screener | Insider Trading Graph View | Insider Watch |
Insider Trading - Spero Therapeutics Inc. (SPRO)
| | "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise" - Peter Lynch What is insider trading>> SPAC List: List of Special Purpose Acquisition Companies |
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2020-06-22 Sale | 2020-06-29 9:21 pm | Spero Therapeutics Inc. | SPRO | Mahadevia Ankit CEO | 17,180 | $14.3 | $245,699 | 65,817 (Direct) | View |
| 2020-07-07 Sale | 2020-07-09 6:48 pm | Spero Therapeutics Inc. | SPRO | Mahadevia Ankit CEO | 3,047 | $14.29 | $43,552 | 65,817 (Direct) | View |
| 2020-09-08 Sale | 2020-09-10 9:51 pm | Spero Therapeutics Inc. | SPRO | Mahadevia Ankit CEO | 774 | $14.25 | $11,030 | 65,817 (Direct) | View |
| 2020-10-13 Sale | 2020-10-15 8:24 pm | Spero Therapeutics Inc. | SPRO | Mahadevia Ankit CEO | 14,472 | $14.28 | $206,709 | 65,817 (Direct) | View |
| 2020-10-23 Sale | 2020-10-27 5:32 pm | Spero Therapeutics Inc. | SPRO | Mahadevia Ankit CEO | 20 | $14.25 | $285 | 65,817 (Direct) | View |
| 2020-11-03 Sale | 2020-11-05 7:00 pm | Spero Therapeutics Inc. | SPRO | Mahadevia Ankit CEO | 9,507 | $14.39 | $136,825 | 65,817 (Direct) | View |
| 2020-11-04 Sale | 2020-11-06 8:48 pm | Spero Therapeutics Inc. | SPRO | Aquilo Capital Management LLC Aquilo Capital L.P. 10% Owner | 174,100 | $14.09 | $2,452,947 | 4,323,042 (Indirect) | View |
| 2020-11-09 Sale | 2020-11-10 7:14 pm | Spero Therapeutics Inc. | SPRO | Aquilo Capital Management LLC Aquilo Capital L.P. 10% Owner | 125,900 | $13.77 | $1,734,071 | 4,197,142 (Indirect) | View |
| 2020-12-16 Sale | 2020-12-18 4:15 pm | Spero Therapeutics Inc. | SPRO | Larkin Cristina COO | 12,000 | $19 | $228,000 | 1,500 (Direct) | View |
| 2020-12-16 Sale | 2020-12-18 4:43 pm | Spero Therapeutics Inc. | SPRO | Aquilo Capital Management LLC Aquilo Capital L.P. 10% Owner | 264,933 | $18.8 | $4,981,260 | 3,932,209 (Indirect) | View |
| 2021-02-01 Sale | 2021-02-04 6:46 pm | Spero Therapeutics Inc. | SPRO | Aquilo Capital Management LLC Aquilo Capital L.P. 10% Owner | 100,000 | $19.02 | $1,901,987 | 3,832,209 (Indirect) | View |
| 2021-02-08 Sale | 2021-02-10 1:35 pm | Spero Therapeutics Inc. | SPRO | Aquilo Capital Management LLC Aquilo Capital L.P. 10% Owner | 3,000 | $21.74 | $65,215 | 3,829,209 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2019-06-05 Option Award | 2019-06-05 6:53 pm | N/A 2029-06-05 | Spero Therapeutics Inc. | SPRO | Pottage John C Jr Director | 6,073 | $0 | 6,073 (Direct) | View |
| 2019-06-05 Option Award | 2019-06-05 6:54 pm | N/A 2029-06-05 | Spero Therapeutics Inc. | SPRO | Smith Cynthia Director | 6,073 | $0 | 6,073 (Direct) | View |
| 2020-01-02 Option Award | 2020-01-06 7:03 pm | N/A 2030-01-02 | Spero Therapeutics Inc. | SPRO | Deshpande Milind Director | 5,408 | $6.47 | 5,408 (Direct) | View |
| 2020-01-02 Option Award | 2020-01-06 7:05 pm | N/A 2030-01-02 | Spero Therapeutics Inc. | SPRO | VINK PATRICK V.J.J. Director | 5,408 | $6.47 | 5,408 (Direct) | View |
| 2020-01-02 Option Award | 2020-01-06 7:06 pm | N/A 2030-01-02 | Spero Therapeutics Inc. | SPRO | FORMELA JEAN FRANCOIS Director | 5,408 | $6.47 | 5,408 (Direct) | View |
| 2020-01-02 Option Award | 2020-01-06 7:09 pm | N/A 2030-01-02 | Spero Therapeutics Inc. | SPRO | THOMAS FRANK E Director | 2,704 | $6.47 | 2,704 (Direct) | View |
| 2020-02-03 Option Award | 2020-02-03 5:28 pm | N/A 2030-02-03 | Spero Therapeutics Inc. | SPRO | Keutzer Timothy Chief Development Officer | 55,000 | $0 | 55,000 (Direct) | View |
| 2020-02-03 Option Award | 2020-02-03 5:32 pm | N/A 2030-02-03 | Spero Therapeutics Inc. | SPRO | Larkin Cristina COO | 55,000 | $0 | 55,000 (Direct) | View |
| 2020-02-03 Option Award | 2020-02-03 5:32 pm | N/A 2030-02-03 | Spero Therapeutics Inc. | SPRO | Mahadevia Ankit CEO | 180,000 | $0 | 180,000 (Direct) | View |
| 2020-02-03 Option Award | 2020-02-03 5:33 pm | N/A 2030-02-03 | Spero Therapeutics Inc. | SPRO | Melnick David A. Chief Medical Officer | 55,000 | $0 | 55,000 (Direct) | View |
| 2020-06-23 Option Award | 2020-06-23 5:33 pm | N/A 2030-06-23 | Spero Therapeutics Inc. | SPRO | Jackson Scott Thomas Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2020-06-22 Exercise | 2020-06-29 9:21 pm | N/A N/A | Spero Therapeutics Inc. | SPRO | Mahadevia Ankit CEO | 2,613 | $5.9 | 68,430 (Direct) | View |
| 2020-06-22 Exercise | 2020-06-29 9:21 pm | N/A N/A | Spero Therapeutics Inc. | SPRO | Mahadevia Ankit CEO | 8,045 | $5.9 | 73,862 (Direct) | View |
| 2020-06-22 Exercise | 2020-06-29 9:21 pm | N/A N/A | Spero Therapeutics Inc. | SPRO | Mahadevia Ankit CEO | 3,880 | $5.9 | 69,697 (Direct) | View |
| 2020-06-22 Exercise | 2020-06-29 9:21 pm | N/A N/A | Spero Therapeutics Inc. | SPRO | Mahadevia Ankit CEO | 2,642 | $5.9 | 68,459 (Direct) | View |
| 2020-06-22 Exercise | 2020-06-29 9:21 pm | N/A 2027-07-05 | Spero Therapeutics Inc. | SPRO | Mahadevia Ankit CEO | 2,613 | $0 | 537,196 (Direct) | View |
| 2020-06-22 Exercise | 2020-06-29 9:21 pm | N/A 2027-07-05 | Spero Therapeutics Inc. | SPRO | Mahadevia Ankit CEO | 8,045 | $0 | 529,151 (Direct) | View |
| 2020-06-22 Exercise | 2020-06-29 9:21 pm | N/A 2027-07-05 | Spero Therapeutics Inc. | SPRO | Mahadevia Ankit CEO | 3,880 | $0 | 525,271 (Direct) | View |
| 2020-06-22 Exercise | 2020-06-29 9:21 pm | N/A 2027-07-05 | Spero Therapeutics Inc. | SPRO | Mahadevia Ankit CEO | 2,642 | $0 | 522,629 (Direct) | View |
| 2020-07-07 Exercise | 2020-07-09 6:48 pm | N/A N/A | Spero Therapeutics Inc. | SPRO | Mahadevia Ankit CEO | 754 | $5.9 | 66,571 (Direct) | View |
| 2020-07-07 Exercise | 2020-07-09 6:48 pm | N/A N/A | Spero Therapeutics Inc. | SPRO | Mahadevia Ankit CEO | 2,293 | $5.9 | 68,110 (Direct) | View |
| 2020-07-07 Exercise | 2020-07-09 6:48 pm | N/A 2027-07-05 | Spero Therapeutics Inc. | SPRO | Mahadevia Ankit CEO | 754 | $0 | 521,875 (Direct) | View |
| 2020-07-07 Exercise | 2020-07-09 6:48 pm | N/A 2027-07-05 | Spero Therapeutics Inc. | SPRO | Mahadevia Ankit CEO | 2,293 | $0 | 519,582 (Direct) | View |
| 2020-09-08 Exercise | 2020-09-10 9:51 pm | N/A N/A | Spero Therapeutics Inc. | SPRO | Mahadevia Ankit CEO | 774 | $5.9 | 66,591 (Direct) | View |
| 2020-09-08 Exercise | 2020-09-10 9:51 pm | N/A 2027-07-05 | Spero Therapeutics Inc. | SPRO | Mahadevia Ankit CEO | 774 | $0 | 518,808 (Direct) | View |
| 2020-10-13 Exercise | 2020-10-15 8:24 pm | N/A N/A | Spero Therapeutics Inc. | SPRO | Mahadevia Ankit CEO | 14,367 | $5.9 | 80,184 (Direct) | View |
| 2020-10-13 Exercise | 2020-10-15 8:24 pm | N/A N/A | Spero Therapeutics Inc. | SPRO | Mahadevia Ankit CEO | 105 | $5.9 | 65,922 (Direct) | View |
| 2020-10-13 Exercise | 2020-10-15 8:24 pm | N/A 2027-07-05 | Spero Therapeutics Inc. | SPRO | Mahadevia Ankit CEO | 14,367 | $0 | 504,441 (Direct) | View |
| 2020-10-13 Exercise | 2020-10-15 8:24 pm | N/A 2027-07-05 | Spero Therapeutics Inc. | SPRO | Mahadevia Ankit CEO | 105 | $0 | 504,336 (Direct) | View |
| 2020-10-27 Option Award | 2020-10-27 5:30 pm | N/A 2030-10-27 | Spero Therapeutics Inc. | SPRO | Pottage John C Jr Director | 7,500 | $0 | 7,500 (Direct) | View |
| 2020-10-27 Option Award | 2020-10-27 5:31 pm | N/A 2030-10-27 | Spero Therapeutics Inc. | SPRO | VINK PATRICK V.J.J. Director | 7,500 | $0 | 7,500 (Direct) | View |
| 2020-10-23 Exercise | 2020-10-27 5:32 pm | N/A N/A | Spero Therapeutics Inc. | SPRO | Mahadevia Ankit CEO | 20 | $5.9 | 65,837 (Direct) | View |
| 2020-10-23 Exercise | 2020-10-27 5:32 pm | N/A 2027-07-05 | Spero Therapeutics Inc. | SPRO | Mahadevia Ankit CEO | 20 | $0 | 504,316 (Direct) | View |
| 2020-10-27 Option Award | 2020-10-27 5:32 pm | N/A 2030-10-27 | Spero Therapeutics Inc. | SPRO | Deshpande Milind Director | 7,500 | $0 | 7,500 (Direct) | View |
| 2020-10-27 Option Award | 2020-10-27 5:34 pm | N/A 2030-10-27 | Spero Therapeutics Inc. | SPRO | Jackson Scott Thomas Director | 7,500 | $0 | 7,500 (Direct) | View |
| 2020-10-27 Option Award | 2020-10-27 5:35 pm | N/A 2030-10-27 | Spero Therapeutics Inc. | SPRO | Smith Cynthia Director | 7,500 | $0 | 7,500 (Direct) | View |
| 2020-10-27 Option Award | 2020-10-27 5:37 pm | N/A 2030-10-27 | Spero Therapeutics Inc. | SPRO | THOMAS FRANK E Director | 7,500 | $0 | 7,500 (Direct) | View |
| 2020-10-27 Option Award | 2020-10-27 5:37 pm | N/A 2030-10-27 | Spero Therapeutics Inc. | SPRO | FORMELA JEAN FRANCOIS Director | 7,500 | $0 | 7,500 (Direct) | View |
| 2020-11-03 Exercise | 2020-11-05 7:00 pm | N/A N/A | Spero Therapeutics Inc. | SPRO | Mahadevia Ankit CEO | 2,137 | $5.9 | 67,954 (Direct) | View |
| 2020-11-03 Exercise | 2020-11-05 7:00 pm | N/A N/A | Spero Therapeutics Inc. | SPRO | Mahadevia Ankit CEO | 7,370 | $5.9 | 73,187 (Direct) | View |
| 2020-11-03 Exercise | 2020-11-05 7:00 pm | N/A 2027-07-05 | Spero Therapeutics Inc. | SPRO | Mahadevia Ankit CEO | 2,137 | $0 | 502,179 (Direct) | View |
| 2020-11-03 Exercise | 2020-11-05 7:00 pm | N/A 2027-07-05 | Spero Therapeutics Inc. | SPRO | Mahadevia Ankit CEO | 7,370 | $0 | 494,809 (Direct) | View |
| 2020-12-02 Option Award | 2020-12-02 6:05 pm | N/A 2030-12-02 | Spero Therapeutics Inc. | SPRO | JOSEPH TAMARA L Chief Legal Officer | 75,000 | $0 | 75,000 (Direct) | View |
| 2020-12-16 Exercise | 2020-12-18 4:15 pm | N/A N/A | Spero Therapeutics Inc. | SPRO | Larkin Cristina COO | 12,000 | $5.9 | 13,500 (Direct) | View |
| 2020-12-16 Exercise | 2020-12-18 4:15 pm | N/A 2027-07-05 | Spero Therapeutics Inc. | SPRO | Larkin Cristina COO | 12,000 | $0 | 8,434 (Direct) | View |
| 2021-01-04 Option Award | 2021-01-05 4:20 pm | N/A 2031-01-04 | Spero Therapeutics Inc. | SPRO | Shukla Sath CFO | 75,000 | $0 | 75,000 (Direct) | View |
| 2021-01-04 Option Award | 2021-01-06 4:27 pm | N/A 2031-01-04 | Spero Therapeutics Inc. | SPRO | Deshpande Milind Director | 2,629 | $13.31 | 2,629 (Direct) | View |
| 2021-01-04 Option Award | 2021-01-06 4:28 pm | N/A 2031-01-04 | Spero Therapeutics Inc. | SPRO | THOMAS FRANK E Director | 1,314 | $13.31 | 1,314 (Direct) | View |
| 2021-01-04 Option Award | 2021-01-06 4:28 pm | N/A 2031-01-04 | Spero Therapeutics Inc. | SPRO | Smith Cynthia Director | 2,629 | $13.31 | 2,629 (Direct) | View |
| 2021-01-04 Option Award | 2021-01-06 4:30 pm | N/A 2031-01-04 | Spero Therapeutics Inc. | SPRO | VINK PATRICK V.J.J. Director | 1,314 | $13.31 | 1,314 (Direct) | View |
| 2021-02-01 Option Award | 2021-02-03 7:44 pm | N/A 2031-02-01 | Spero Therapeutics Inc. | SPRO | Melnick David A. Chief Medical Officer | 57,432 | $0 | 57,432 (Direct) | View |
| 2021-02-01 Option Award | 2021-02-03 7:44 pm | N/A 2031-02-01 | Spero Therapeutics Inc. | SPRO | Mahadevia Ankit Director | 179,319 | $0 | 179,319 (Direct) | View |
| 2021-02-01 Option Award | 2021-02-03 7:47 pm | N/A 2031-02-01 | Spero Therapeutics Inc. | SPRO | Larkin Cristina COO | 57,432 | $0 | 57,432 (Direct) | View |
| 2021-02-01 Option Award | 2021-02-03 7:52 pm | N/A 2031-02-01 | Spero Therapeutics Inc. | SPRO | Keutzer Timothy Chief Development Officer | 57,432 | $0 | 57,432 (Direct) | View |